Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
RESPONSE: A Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Roberts, Stuart
(Primary Chief Investigator (PCI))
Gastroenterology
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
16/07/21
→
31/12/24
View all
View less
Keywords
Gastroenterology
Primary Biliary Cholangitis
Clinical trial